Beck Bode’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Beck Bode's ALNY Position: Q1 2025 in Review
Beck Bode sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2025, closing a stake of 56,017 shares — an estimated $13.2M sold.
Beck Bode first reported a position in ALNY in Q4 2024 and held it in 1 quarter. The position peaked at $13.2M in Q4 2024. 630 funds tracked by Wall St. Rank hold ALNY as of Q1 2025.
- Beck Bode reported no remaining Alnylam Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Beck Bode sold 56,017 Alnylam Pharmaceuticals shares in Q1 2025, an estimated $13.2M.
- Beck Bode first reported a position in Alnylam Pharmaceuticals in Q4 2024 and held it in 1 quarter.
- Beck Bode's Alnylam Pharmaceuticals position peaked at $13.2M in Q4 2024.
- 630 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2025.
Based on Beck Bode's 13F filing for Q1 2025, filed 14 May 2025.